Juniper Biomedical is a neuromodulation MedTech company that is dramatically improving therapy for patients with pelvic health conditions.
Juniper Biomedical has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Juniper Biomedical's investors include MassChallenge, National Institutes of Health, Massachusetts Medical Device Development Center (M2D2), MedTech Innovator, Beacon Angels.
Juniper Biomedical is headquartered in Worcester, United States.
Juniper Biomedical is a neuromodulation MedTech company that is dramatically improving therapy for patients with pelvic health conditions.
Juniper Biomedical is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Juniper Biomedical — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/juniper-biomedical. Accessed July 19, 2026.
VCBacked. (2025). Juniper Biomedical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/juniper-biomedical
{{cite web |title=Juniper Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/juniper-biomedical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated